Antares Pharma, Inc. (ATRS)

Stock-Based Compensation

$1.94M

Quarterly · Period ending: · USD

ATRS logo

ATRS Stock-Based Compensation

Latest reported$1.94M
ATRS Quarterly Stock-Based Comp ($0.00 → $1.94M)
High-resolution chart · PNG

ATRS stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.